EntryPoint Capital, LLC
- SEC CIK
- 0001992519
- Latest filing
- Aug 13, 2026
AQST holding history
Aquestive Therapeutics, Inc. in every 13F filed by EntryPoint Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AQST overviewAll 13F holders of AQSTFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −28,745−100.0% | Sold out | Holders |
| Q4 2025 | 28,745 | $185.7K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 28,745 | $160.7K | 0.1% | −120,411−80.7% | Reduced | Holders |
| Q2 2025 | 149,156 | $493.7K | 0.2% | −43,600−22.6% | Reduced | Holders |
| Q1 2025 | 192,756 | $559.0K | 0.3% | +56,959+41.9% | Added | Holders |
| Q4 2024 | 135,797 | $483.4K | 0.2% | +112,210+475.7% | Added | Holders |
| Q3 2024 | 23,587 | $117.5K | 0.1% | −38,614−62.1% | Reduced | Holders |
| Q2 2024 | 62,201 | $161.7K | 0.1% | +62,201 | New | Holders |